New Sodium Mefenamate – Nicotinamide Multicomponent Crystal Development to Modulate Solubility and Dissolution: Preparation, Structural, and Performance Study-Reference-Cited by-同舟云学术

New Sodium Mefenamate – Nicotinamide Multicomponent Crystal Development to Modulate Solubility and Dissolution: Preparation, Structural, and Performance Study

Published:2021-09 Issue:9 Volume:110 Page:3246-3260
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Nugrahani Ilma,Fisandra Felicia,Horikawa Ayano,Uekusa Hidehiro

Funder

Bandung Institute of Technology

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference62 articles.

1. Cocrystal formation, crystal structure, solubility and permeability studies for novel 1,2,4-thiadiazole derivative as a potent neuroprotector;Surov;Eur J Pharm Sci,2017

2. The isonicotinamide cocrystal promotes inhibitory effects of naringenin on nonalcoholic fatty liver disease in mice;Jiang;J Drug Deliv Sci Tech,2020

3. Solubility and stability advantages of a new cocrystal of berberine chloride with fumaric acid;Yang;ACS Omega,2020

4. Enabling tablet product development of 5-fluorocytosine through integrated crystal and particle engineering;Perumalla;J Pharm Sci,2015

5. Cocrystal habit engineering to improve drug dissolution and alter derived powder properties;Serrano;J Pharm Pharmacol,2016

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the potential of new mefenamic acid derivatives as α-glucosidase inhibitors: Structure-activity relationship, in-vitro and in-silico studies;Journal of Molecular Structure;2024-11

2. Crystal Engineering: A Versatile Platform for Pulmonary Drug Delivery;Pulmonary Drug Delivery Systems: Material and Technological Advances;2023

3. Formation of a Stable Co-Amorphous System for a Brick Dust Molecule by Utilizing Sodium Taurocholate with High Glass Transition Temperature;Pharmaceutics;2022-12-27

4. Non-Covalent Reactions Supporting Antiviral Development;Molecules;2022-12-19

5. Pharmaceutical Co-crystal of Antiviral Agent Efavirenz with Nicotinamide for the Enhancement of Solubility, Physicochemical Stability, and Oral Bioavailability;AAPS PharmSciTech;2022-11-29